Nearly 2 to 1 patients prefer AirFit F30 over the current minimal-contact full face market leader SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) today announced the availability of its first ...
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback